ES534202A0 - Un procedimiento para preparar nuevos compuestos de cefem. - Google Patents

Un procedimiento para preparar nuevos compuestos de cefem.

Info

Publication number
ES534202A0
ES534202A0 ES534202A ES534202A ES534202A0 ES 534202 A0 ES534202 A0 ES 534202A0 ES 534202 A ES534202 A ES 534202A ES 534202 A ES534202 A ES 534202A ES 534202 A0 ES534202 A0 ES 534202A0
Authority
ES
Spain
Prior art keywords
procedure
preparing new
cefem compounds
new cefem
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES534202A
Other languages
English (en)
Other versions
ES8505690A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838300122A external-priority patent/GB8300122D0/en
Priority claimed from GB838317496A external-priority patent/GB8317496D0/en
Priority claimed from GB838329768A external-priority patent/GB8329768D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES534202A0 publication Critical patent/ES534202A0/es
Publication of ES8505690A1 publication Critical patent/ES8505690A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20Quaternary compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Data Exchanges In Wide-Area Networks (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
ES534202A 1982-12-06 1984-07-11 Un procedimiento para preparar nuevos compuestos de cefem. Expired ES8505690A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8234755 1982-12-06
GB838300122A GB8300122D0 (en) 1983-01-05 1983-01-05 Cephem compounds
GB838317496A GB8317496D0 (en) 1983-06-28 1983-06-28 Cephem compounds
GB838329768A GB8329768D0 (en) 1983-11-08 1983-11-08 Cephem compounds

Publications (2)

Publication Number Publication Date
ES534202A0 true ES534202A0 (es) 1985-06-01
ES8505690A1 ES8505690A1 (es) 1985-06-01

Family

ID=27449416

Family Applications (3)

Application Number Title Priority Date Filing Date
ES527790A Expired ES8506729A1 (es) 1982-12-06 1983-12-05 Un procedimiento para preparar nuevos compuestos de cefem
ES534202A Expired ES8505690A1 (es) 1982-12-06 1984-07-11 Un procedimiento para preparar nuevos compuestos de cefem.
ES534203A Expired ES8506730A1 (es) 1982-12-06 1984-07-11 Un procedimiento para preparar nuevos compuestos de cefem.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES527790A Expired ES8506729A1 (es) 1982-12-06 1983-12-05 Un procedimiento para preparar nuevos compuestos de cefem

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES534203A Expired ES8506730A1 (es) 1982-12-06 1984-07-11 Un procedimiento para preparar nuevos compuestos de cefem.

Country Status (17)

Country Link
US (2) US4584290A (es)
EP (1) EP0111281B1 (es)
JP (1) JPH0639475B2 (es)
KR (1) KR840007011A (es)
AU (1) AU2174783A (es)
CH (1) CH656882A5 (es)
DE (1) DE3381627D1 (es)
DK (1) DK554483A (es)
ES (3) ES8506729A1 (es)
FI (1) FI834413A (es)
FR (1) FR2537141B1 (es)
GB (1) GB2139617B (es)
GR (1) GR79043B (es)
IT (1) IT1168734B (es)
NO (1) NO834463L (es)
OA (1) OA07602A (es)
PT (1) PT77772B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79043B (es) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co
WO1994006804A1 (en) * 1992-09-18 1994-03-31 Otsuka Kagaku Kabushiki Kaisha Cephem compound, process for producing the same, and medicine containing the same
WO1995025109A1 (fr) * 1994-03-17 1995-09-21 Otsuka Kagaku Kabushiki Kaisha Compose de cephem, procede d'obtention de ce compose et agent antibacterien contenant celui-ci
AU4496896A (en) * 1995-01-30 1996-08-21 Takeda Chemical Industries Ltd. Cephem compounds, their production and use
WO1996038451A1 (en) * 1995-05-29 1996-12-05 Takeda Chemical Industries, Ltd. Cephem compounds, their production and use
EP0781435B1 (en) * 1995-07-13 2003-03-05 Koninklijke Philips Electronics N.V. Method and system for data repetition between logically successive clusters
MY127641A (en) * 1995-10-12 2006-12-29 Essential Therapeutics Inc Cephalosporin antibiotics
US6025352A (en) * 1997-09-29 2000-02-15 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
US6030965A (en) * 1997-09-30 2000-02-29 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
AUPO973297A0 (en) * 1997-10-10 1997-11-06 Fujisawa Pharmaceutical Co., Ltd. New compound
WO2003072582A1 (en) * 2002-02-28 2003-09-04 Lg Life Sciences Ltd. Novel cephalosporin compounds and process for preparing the same
US20130065874A1 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CA2906151A1 (en) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN104177408B (zh) * 2014-09-12 2016-09-07 衡水衡林生物科技有限公司 (z)-2-(5-二氯磷酰氨基-1,2,4-噻二唑-3-基)-2-乙氧亚胺基乙酰氯的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO801501L (no) * 1979-05-23 1980-11-24 Rhone Poulenc Ind Fremgangsmaate for fremstilling av 3-tiovinylcefalosporiner
FR2494280A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine et leur preparation
FR2494274A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles thiovinyl-3 cephalosporines, leur preparation et les medicaments qui les contiennent
GR79043B (es) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
PT77772B (en) 1986-04-17
IT8324035A0 (it) 1983-12-05
JPH0639475B2 (ja) 1994-05-25
ES534203A0 (es) 1985-07-16
PT77772A (en) 1984-01-01
ES527790A0 (es) 1985-07-16
FR2537141A1 (fr) 1984-06-08
EP0111281A3 (en) 1985-07-03
EP0111281B1 (en) 1990-06-06
GR79043B (es) 1984-10-02
FI834413A (fi) 1984-06-07
NO834463L (no) 1984-06-07
ES8506729A1 (es) 1985-07-16
AU2174783A (en) 1984-06-14
GB8331713D0 (en) 1984-01-04
ES8506730A1 (es) 1985-07-16
IT1168734B (it) 1987-05-20
JPS59130292A (ja) 1984-07-26
OA07602A (fr) 1985-03-31
CH656882A5 (de) 1986-07-31
GB2139617A (en) 1984-11-14
DK554483D0 (da) 1983-12-01
FI834413A0 (fi) 1983-12-02
KR840007011A (ko) 1984-12-04
DK554483A (da) 1984-06-07
US4584290A (en) 1986-04-22
DE3381627D1 (de) 1990-07-12
US4719206A (en) 1988-01-12
FR2537141B1 (fr) 1987-02-27
EP0111281A2 (en) 1984-06-20
GB2139617B (en) 1986-09-24
ES8505690A1 (es) 1985-06-01

Similar Documents

Publication Publication Date Title
ES534751A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES534202A0 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES521153A0 (es) Un procedimiento para preparar compuestos de quinolona.
ES523195A0 (es) Un procedimiento para preparar alquil-glicosidos
ES537668A0 (es) Un procedimiento para preparar n-formil-3-fenoxi-1-azetidincarboxamidas
ES513296A0 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES521318A0 (es) Un procedimiento para la preparacion de compuestos de bencimidazol.
ES519652A0 (es) Un procedimiento para obtener s-adenosil-metionina.
ES520364A0 (es) Un procedimiento para preparar compuestos de cefem.
AR231308A1 (es) Un procedimiento para preparar 1-be-d-ribofuranosil-1,2,4-triazolcarboxamida rivavirina
ES503134A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES522403A0 (es) Un procedimiento para la preparacion de nuevos compuestos derivados de aziridina.
ES521047A0 (es) Un procedimiento para preparar compuestos de cefem.
ES523193A0 (es) Un procedimiento para preparar 3-fenoxi-1-azetidincarbo-xznmidas
ES518758A0 (es) Un procedimiento para preparar azetidinas.
ES505498A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES538192A0 (es) Un procedimiento para preparar un 2-bromo-6b-9a - difluoro-11b, 17a, 21-trihidroxi-1, 4-pregnadien-3, 20-diona-17, 21-diester
ES524772A0 (es) Un procedimiento para preparar fenilanilinas-n.sustituidas.
ES522716A0 (es) Un procedimiento para preparar un derivado de pirazol.
ES519936A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES520826A0 (es) Un procedimiento para obtener compuestos de ribofuranosilselenazol-4-carboxamida.
ES523682A0 (es) Un procedimiento para preparar compuestos de cefalosporina.
ES537961A0 (es) Un metodo para preparar compuestos de fenilpiperazina sustituida.
ES527108A0 (es) Un procedimiento para preparar 2-alcoxi-5-(piridinil) piridinas
ES522570A0 (es) Un procedimiento para preparar nuevas dihidropiridinas.